Osteopenia: Bone Density Loss, Causes, Risk Factors, and Management Strategies

Osteopenia is a condition of lower-than-normal bone mineral density (BMD)—a precursor to osteoporosis. It often has no symptoms until a fracture occurs.

Causes and Risk Factors

Non-Modifiable

• Aging: Bone loss accelerates after 50.
• Female sex: Postmenopausal estrogen decline accelerates bone loss.
• Family history: Genetics influence peak bone mass and loss rate.
• Race/ethnicity: White and Asian women at highest risk.
• Small frame: Less bone mass to draw from.

Modifiable

• Low calcium/vitamin D intake
• Sedentary lifestyle
• Smoking
• Excessive alcohol (>2 drinks/day)
• Certain medications: Long-term corticosteroids, some anticonvulsants, proton pump inhibitors, thyroid hormone excess.
• Medical conditions: Hyperthyroidism, celiac disease, rheumatoid arthritis, eating disorders.

Diagnosis

DEXA (dual-energy X-ray absorptiometry) scan measures BMD at hip and spine. Results reported as T-score:

• Normal: T-score ≥ -1.0
• Osteopenia: T-score between -1.0 and -2.5
• Osteoporosis: T-score ≤ -2.5

Treatment and Prevention

Lifestyle (Foundation for All)

• Weight-bearing exercise (walking, jogging, dancing) + resistance training 3×/week.
• Calcium: 1,000–1,200 mg/day from food (dairy, leafy greens, fortified foods) + supplements if needed.
• Vitamin D: 800–2,000 IU/day (target blood level >30 ng/mL).
• Quit smoking; limit alcohol.
• Fall prevention: balance exercises, home safety, vision checks.

Medications (Case-by-Case)

Considered if high fracture risk (FRAX score) or progression to osteoporosis:

• Bisphosphonates (alendronate, risedronate)
• Denosumab
• Anabolic agents (teriparatide, romosozumab) for severe cases.

Regular DEXA monitoring (every 1–2 years) tracks response. Discuss individualized plan with your healthcare provider.